Skip to main content
    C

    Citius Pharmaceuticals Inc (CTXR)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.52
    -0.01 (-1.67%)

    Market Cap: $14.69M

    Last updated: Nov 17, 2026 at 4:15 PM ET

    Citius Pharmaceuticals Inc (CTXR) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Citius Pharmaceuticals (CTXR) has a latest price of $0.52 on Nov 17, 2026, 66.3% below its 52-week high of $1.54. Its price fell 47.0% over the past 12 months. The month-end price fell 99.6% since Jul 2017, a compound annual decline of 44.9%.

    Price Chart

    From Jul 2017 to Oct 2026, its highest month-end close was $130.75 in Jul 2017 and its lowest $0.52 in Oct 2026, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart CTXR with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for CTXR.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 18.6%, and over 6 months it fell 6.4%. The month-end price fell 97.2% over the 3 years through Oct 2026, a compound annual decline of 69.7%.

    PeriodChange
    1 month+21.3%
    3 months-18.6%
    6 months-6.4%
    12 months-47.0%
    12 months, with dividends-47.0%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years-97.2%-69.7%
    5 years-98.9%-59.3%
    Since Jul 2017-99.6%-44.9%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2021, when the price rose 51.0%, and its weakest was 2025, when it fell 80.6%.

    YearCloseChange
    2026 through Oct 2026$0.52-32.7%
    2025$0.78-80.6%
    2024$4.00-78.8%
    2023$18.91-4.2%
    2022$19.75-48.7%
    2021$38.50+51.0%
    2020$25.500.0%
    2019$25.50-1.9%
    2018$26.00-72.6%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 0.5% below its 50-day average of $0.52 and 19.0% below its 200-day average of $0.64.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$0.52
    52-week high$1.54-66.3%
    52-week low$0.37+40.2%
    50-day average$0.52-0.5%
    200-day average$0.64-19.0%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 98.6%.

    MeasureValue
    1-year beta1.92
    Largest fall, 1 year-74.3%
    Largest fall, 3 years-98.6%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About CTXR

    What is CTXR's 1-year price change?

    Citius Pharmaceuticals's price fell 47.0% over the past 12 months. With dividends included, the 12-month total return was -47.0%.

    What is CTXR's 5-year price change?

    Citius Pharmaceuticals's month-end price fell 98.9% over the 5 years through Oct 2026, a compound annual decline of 59.3%. These figures leave out dividends.

    What is CTXR's 52-week high and low?

    Citius Pharmaceuticals's 52-week high is $1.54 and its 52-week low is $0.37. Its latest price of $0.52 on Nov 17, 2026 is 66.3% below the high.

    What is CTXR's beta?

    Citius Pharmaceuticals's 1-year beta against the S&P 500 is 1.92, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 74.3%.

    Is the CTXR chart free?

    Yes. Advanced Charting for CTXR is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.